Halozyme Therapeutics, Inc. (FRA:RV7)
Germany · Delayed Price · Currency is EUR 59.82
+2.68 (4.69%)
At close: Jan 5, 2026
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €7.33 billion as of January 9, 2026. Its market cap has increased by 26.96% in one year.
Market Cap
7.33B
Enterprise Value
8.05B
Revenue
1.06B
Ranking
n/a
PE Ratio
14.44
Stock Price
€59.82
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 7.33B, an increase of 5,072.13%. That is a compound annual growth rate of 19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 7.33B | 8.69% |
| Dec 31, 2025 | 6.74B | 14.73% |
| Dec 31, 2024 | 5.88B | 33.01% |
| Dec 29, 2023 | 4.42B | -38.64% |
| Dec 30, 2022 | 7.20B | 44.69% |
| Dec 31, 2021 | 4.98B | 5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |